SCC-containing medium can be a feasible xeno-free alternative to expand hMSCs for advanced therapies.
No takes yet. Share an insight, caveat, or question.
Blázquez-Prunera et al. (2017) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: